ProMIS Neurosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -11,122 | -11,580 | -10,117 | -7,347 |
EBIT | -10,184 | -7,348 | ||
Net Income | -10,674 | -11,580 | -10,117 | -7,347 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,051 | -10,181 | -3,854 | -4,926 |
Cash | 6,116 | 15,399 | 4,510 | 8,364 |
Basic Shares | 1,757 | 1,394 | 1,394 | 1,394 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $8 |
Gross Profit | -10,444 | -21,781 | ||
EBITDA | -40,167 | 2,855 | -17,809 | -17,768 |
EBIT | 2,702,098 | -17,837 | -17,780 | |
Net Income | -39,719,147 | 2,778 | -17,506 | -18,062 |
Net Change In Cash | 0 | 0 | 0 | 8 |
Free Cash Flow | -28,118,579 | -27,182 | -10,843 | -17,035 |
Cash | 6,116 | 13,291 | 12,598 | 7,955 |
Basic Shares | 1,756,844 | 1,058 | 491 | 300 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$30.05 |
2025-09-30 | -$0.24 |
2025-06-30 | -$0.29 |
